Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Xue X, You S, Zhang Q, Wu Y, Zou GZ, Wang PC, Zhao YL, Xu Y, Jia L, Zhang X, Liang XJ. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction. Mol Pharm. 2012 Mar 05; 9(3):634-44.

View in: PubMed

subject areas

Antineoplastic Agents
Apoptosis
Cell Line, Tumor
Cisplatin
Drug Resistance, Neoplasm
Humans
Mitochondria
Models, Biological
Organoplatinum Compounds

authors with profiles

Paul Wang

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support